Table 2 |
|||||||
|
Correlation of immunohistochemical staining results with histological diagnosis of thyroid lesions |
|||||||
|
Markers |
Benign (98) |
Malignant (54) |
|||||
|
Non-Neoplastic HN 52 (%) |
Neoplastic FA/HA 46 (%) |
Total 98 (%) |
FC 22 |
PTC 20 |
FVPC 12 |
Total 54 (%) |
|
|
|
|||||||
|
Gal-3 |
8 (15.3%) |
19 (41.3%) |
27(27.5%) |
18 (81.8%) |
18 (90%) |
10 (83.3%) |
46 (85.1%) |
|
RET |
9 (17.3%) |
21 (45.6%) |
30(30.6%) |
16 (72.7%) |
18 (90%) |
11 (91.7%) |
45 (83.3%) |
|
HBME-1 |
9 (17.3%) |
26 (56.5%) |
35(35.7%) |
18 (81.8%) |
18 (90%) |
11 (91.7%) |
47 (87%) |
|
CK-19 |
8(15.3%) |
23 (50%) |
31(31.6%) |
19 (86.3%) |
17 (85%) |
10 (83.3%) |
47 (85.1%) |
|
|
|||||||
|
HN: hyperplastic/adenomatoid nodule; FA: Follicular adenoma; HA: Hurthle cell adenoma; FC: Follicular carcinoma; PTC: Papillary thyroid carcinoma; FVPC: Follicular variant of papillary carcinoma |
|||||||
|
Saleh et al. Diagnostic Pathology 2010 5:9 doi:10.1186/1746-1596-5-9 |
|||||||
